Rationale and design of switch Swedeheart: A registry-based, stepped-wedge, cluster-randomized, open-label multicenter trial to compare prasugrel and ticagrelor for treatment of patients with acute coronary syndrome-Reference-Cited by-同舟云学术

Rationale and design of switch Swedeheart: A registry-based, stepped-wedge, cluster-randomized, open-label multicenter trial to compare prasugrel and ticagrelor for treatment of patients with acute coronary syndrome

Published:2022-09 Issue: Volume:251 Page:70-77
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Omerovic Elmir,Erlinge David,Koul Sasha,Frobert Ole,Andersson Jonas,Ponten Johan,Björklund Fredrik,Kastberg Robert,Petzold Max,Ljungman Charlotta,Bolin Kristian,Redfors Björn^ORCID

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference21 articles.

1. Ticagrelor versus clopidogrel in patients with acute coronary syndromes;Wallentin;N Engl J Med,2009

2. Prasugrel versus clopidogrel in patients with acute coronary syndromes;Wiviott;N Engl J Med,2007

3. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American college of cardiology/American heart association task force on practice guidelines;Amsterdam;J Am Coll Cardiol,2014

4. Adverse events in patients with high platelet reactivity following successful chronic total occlusion PCI: the assessment of dual antiplatelet therapy with drug-eluting stents (ADAPT-DES) study;Finn;Am Heart J,2019

5. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American college of cardiology foundation/American heart association task force on practice guidelines;O'Gara;Circulation,2013

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Five basic rules for making non-inferiority trials more meaningful;Scandinavian Cardiovascular Journal;2024-07-08

2. Regulatory bodies and health care systems should systematically evaluate the safety and cost-effectiveness of new cardiovascular treatments in health care registries using prospectively designed protocols;Scandinavian Cardiovascular Journal;2024-05-02

3. Maximizing the Value of Real-World Data and Real-World Evidence to Accelerate Healthcare Transformation in China: Summary of External Advisory Committee Meetings;Pharmaceutical Medicine;2024-04-04

4. Current Strategies to Guide the Antiplatelet Therapy in Acute Coronary Syndromes;International Journal of Molecular Sciences;2024-04-03

5. Potent P2Y12 Inhibitor Selection and De-Escalation Strategies in Acute Coronary Syndrome Patients Undergoing PCI: Systematic Review and Meta-analysis;CJC Open;2023-12